La bourse ferme dans 8 h 19 min

Becton, Dickinson and Company (BDX)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
233,15+0,94 (+0,40 %)
À la clôture : 04:00PM EDT
233,83 +0,68 (+0,29 %)
Échanges après Bourse : 06:58PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein73 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Thomas E. Polen Jr.President, CEO & Chairman3,46MS.O.1973
Mr. Christopher J. DelOreficeExecutive VP & CFO1,6MS.O.1972
Ms. Shana Carol NealExecutive VP & Chief People Officer1,79MS.O.1966
Mr. David B. HickeyExecutive VP & President of Life Sciences Segment1,11M562,03k1964
Mr. Michael GarrisonExecutive VP & President of Medical segment1,73MS.O.1970
Mr. Thomas J. SpoerelSenior VP, Controller & Chief Accounting OfficerS.O.S.O.1979
Ms. Elizabeth McCombsExecutive VP & Chief Technology OfficerS.O.S.O.1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardS.O.S.O.S.O.
Ms. Denise Russell FlemingExecutive VP of Technology & Global Services and Chief Information OfficerS.O.S.O.1970
Mr. Greg RodetisHead of Investor RelationsS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Becton, Dickinson and Company en date du 1 avril 2024 est 10. Les scores principaux sont Audit : 10; Société : 8; Droits des actionnaires : 9; Compensation : 10.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.